- Home
- ASRT vs XTNT Comparison
ASRT vs XTNT Comparison
Compare ASRT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- XTNT
- Stock Information
- Founded
- ASRT 1995
- XTNT N/A
- Country
- ASRT United States
- XTNT United States
- Employees
- ASRT N/A
- XTNT N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASRT Health Care
- XTNT Health Care
- Exchange
- ASRT Nasdaq
- XTNT Nasdaq
- Market Cap
- ASRT 65.7M
- XTNT 60.9M
- IPO Year
- ASRT 1997
- XTNT N/A
- Fundamental
- Price
- ASRT $0.61
- XTNT $0.45
- Analyst Decision
- ASRT Strong Buy
- XTNT Strong Buy
- Analyst Count
- ASRT 3
- XTNT 1
- Target Price
- ASRT $3.08
- XTNT $3.00
- AVG Volume (30 Days)
- ASRT 480.8K
- XTNT 67.4K
- Earning Date
- ASRT 05-05-2025
- XTNT 05-14-2025
- Dividend Yield
- ASRT N/A
- XTNT N/A
- EPS Growth
- ASRT N/A
- XTNT N/A
- EPS
- ASRT N/A
- XTNT N/A
- Revenue
- ASRT $124,961,000.00
- XTNT $117,267,000.00
- Revenue This Year
- ASRT N/A
- XTNT $15.56
- Revenue Next Year
- ASRT $11.20
- XTNT $22.39
- P/E Ratio
- ASRT N/A
- XTNT N/A
- Revenue Growth
- ASRT N/A
- XTNT 28.44
- 52 Week Low
- ASRT $0.51
- XTNT $0.33
- 52 Week High
- ASRT $1.80
- XTNT $0.97
- Technical
- Relative Strength Index (RSI)
- ASRT 39.17
- XTNT 50.03
- Support Level
- ASRT $0.58
- XTNT $0.34
- Resistance Level
- ASRT $0.80
- XTNT $0.43
- Average True Range (ATR)
- ASRT 0.05
- XTNT 0.04
- MACD
- ASRT 0.00
- XTNT -0.00
- Stochastic Oscillator
- ASRT 34.48
- XTNT 64.71
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.